/PRNewswire/ Trial lawyers from Dallas-based Fears Nachawati Law Firm praised a federal judge s ruling today that rejected a settlement from Bayer AG that.
Controversial Monsanto Roundup Weed Killer Settlement Under Scrutiny
Fears Nachawati trial lawyers: Settlement asks healthy individuals to make impossible choices about future cancer diagnoses
News provided by
Share this article
Share this article
SAN FRANCISCO, May 19, 2021 /PRNewswire/ Lawyers representing thousands of cancer victims exposed to Bayer AG s Roundup weed killer called on a federal judge to reject a proposed settlement that would allow Bayer (OTCMKTS: BAYRY) to continue selling the herbicide while limiting legal options for individuals who are diagnosed with cancer in the future.
The provision allowing Bayer to continue selling Roundup was just one of the controversial details highlighted by objectors to the settlement during a hearing on May 19 before U.S. District Court Judge Vince Chhabria. Among other things, the proposal would require healthy individuals who have already been exposed to Roundup to relinquish their right to sue if they are later diagnosed w
Share this article
Share this article
SAN FRANCISCO, May 14, 2021 /PRNewswire/ A federal appellate ruling upholding findings that Bayer AG s Monsanto Roundup weed killer caused a California man s non-Hodgkins lymphoma cancer deals a blow to efforts by Bayer AG to push through a flawed settlement of thousands of pending cancer lawsuits, trial lawyers with Dallas-based Fears Nachawati Law Firm said Friday.
Fears Nachawati lawyers, who represent more than 4,000 cancer victims in litigation against Bayer AG (OTCMKTS: BAYRY), will discuss the significance of the ruling in
Hardeman v. Monsanto and the status of the proposed settlement during a Facebook Live news conference on Monday at 11 a.m. Central. Click here for details: https://bit.ly/3bramVi
/PRNewswire/ The Fears Nachawati Law Firm is proud to announce the addition of veteran trial lawyer Gibbs Henderson, adding significant expertise to the.
More than 40,000 Cancer Claims Remain Unresolved from Proposed Bayer Monsanto Roundup Weed Killer Lawsuit Settlement
Many cancer victims critical of settlement structure, vow to pursue jury trials
News provided by
Share this article
Share this article
DALLAS, April 26, 2021 /PRNewswire/ More than 40,000 current claims on behalf of individuals diagnosed with non-Hodgkins lymphoma after exposure to the Bayer Monsanto Roundup herbicide remain unresolved as criticism mounts that a proposed settlement framework is inconsistent and unfair to cancer victims.
Plaintiffs in multidistrict litigation (MDL) against Roundup maker Bayer AG (OTCMKTS: BAYRY) increasingly see a jury trial as the only avenue for justice, said trial lawyer